# Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis

> **NCT02255825** · NA · WITHDRAWN · sponsor: **University of California, San Diego**

## Conditions studied

- Major Fetal Anomaly

## Interventions

- **GENETIC:** Whole Genome Sequencing
- **PROCEDURE:** Amniocentesis
- **OTHER:** Psychosocial assessment

## Key facts

- **NCT ID:** NCT02255825
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-10
- **Primary completion:** 2019-06-04
- **Final completion:** 2019-06-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Awaiting verification of assay
- **Last updated:** 2019-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02255825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02255825, "Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02255825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
